Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax®) in healthy adolescents and adults
Year: 1995
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Vaccine
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1968296648
